Labgenomics Co Stock Fundamentals
| 084650 Stock | KRW 2,770 20.00 0.73% |
LabGenomics Co fundamentals help investors to digest information that contributes to LabGenomics' financial success or failures. It also enables traders to predict the movement of LabGenomics Stock. The fundamental analysis module provides a way to measure LabGenomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LabGenomics stock.
LabGenomics |
LabGenomics Co Company Current Valuation Analysis
LabGenomics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current LabGenomics Current Valuation | 356.77 B |
Most of LabGenomics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LabGenomics Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, LabGenomics Co has a Current Valuation of 356.77 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Healthcare Providers & Services industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.
LabGenomics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LabGenomics's current stock value. Our valuation model uses many indicators to compare LabGenomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LabGenomics competition to find correlations between indicators driving LabGenomics's intrinsic value. More Info.LabGenomics Co is rated second in return on equity category among related companies. It is rated second in return on asset category among related companies reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LabGenomics Co is roughly 92.12 . Comparative valuation analysis is a catch-all model that can be used if you cannot value LabGenomics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LabGenomics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LabGenomics' earnings, one of the primary drivers of an investment's value. LabGenomics Co is rated second in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Healthcare Providers & Services industry is presently estimated at about 713.53 Billion. LabGenomics totals roughly 356.77 Billion in current valuation claiming about 50% of equities under Healthcare Providers & Services industry.LabGenomics Fundamentals
| Return On Equity | 42.82 | |||
| Return On Asset | 0.46 | |||
| Profit Margin | 0.38 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | 356.77 B | |||
| Shares Outstanding | 9.08 M | |||
| Shares Owned By Insiders | 12.68 % | |||
| Shares Owned By Institutions | 1.09 % | |||
| Price To Sales | 2.02 X | |||
| Revenue | 202.41 B | |||
| Gross Profit | 71.32 B | |||
| EBITDA | 70.81 B | |||
| Net Income | 83.85 B | |||
| Cash And Equivalents | 70.53 B | |||
| Total Debt | 4.4 B | |||
| Cash Flow From Operations | 66.08 B | |||
| Target Price | 25000.0 | |||
| Number Of Employees | 233 | |||
| Beta | -0.96 | |||
| Market Capitalization | 61 B | |||
| Total Asset | 204.29 B | |||
| Z Score | 7.8 | |||
| Net Asset | 204.29 B |
About LabGenomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LabGenomics Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LabGenomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LabGenomics Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LabGenomics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the LabGenomics information on this page should be used as a complementary analysis to other LabGenomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for LabGenomics Stock analysis
When running LabGenomics' price analysis, check to measure LabGenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LabGenomics is operating at the current time. Most of LabGenomics' value examination focuses on studying past and present price action to predict the probability of LabGenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LabGenomics' price. Additionally, you may evaluate how the addition of LabGenomics to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |